139 related articles for article (PubMed ID: 2701569)
1. 19F MRS studies of fluoropyrimidine chemotherapy. A review.
McSheehy PM; Griffiths JR
NMR Biomed; 1989 Nov; 2(4):133-41. PubMed ID: 2701569
[TBL] [Abstract][Full Text] [Related]
2. Assignment and pH dependence of the 19F-NMR resonances from the fluorouracil anabolites involved in fluoropyrimidine chemotherapy.
Lutz NW; Hull WE
NMR Biomed; 1999 Jun; 12(4):237-48. PubMed ID: 10421915
[TBL] [Abstract][Full Text] [Related]
3. [Fluorine-19 nuclear magnetic resonance spectroscopy: a privileged tool for the study of the metabolism and pharmacokinetics of fluoropyrimidines].
Malet-Martino MC; Martino R; Armand JP
Bull Cancer; 1990; 77(12):1223-44. PubMed ID: 2081282
[TBL] [Abstract][Full Text] [Related]
4. In vivo and ex vivo magnetic resonance spectroscopy as applied to pharmacokinetic studies with anticancer agents: a review.
Newell DR; Maxwell RJ; Golding BT
NMR Biomed; 1992; 5(5):273-8. PubMed ID: 1449968
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance spectroscopy: a powerful tool for drug metabolism studies.
Malet-Martino MC; Martino R
Biochimie; 1992; 74(9-10):785-800. PubMed ID: 1467338
[TBL] [Abstract][Full Text] [Related]
6. Fluorine nuclear magnetic resonance, a privileged tool for metabolic studies of fluoropyrimidine drugs.
Martino R; Malet-Martino M; Gilard V
Curr Drug Metab; 2000 Nov; 1(3):271-303. PubMed ID: 11465049
[TBL] [Abstract][Full Text] [Related]
7. Monitoring pharmacokinetics of anticancer drugs: non-invasive investigation using magnetic resonance spectroscopy.
Griffiths JR; Glickson JD
Adv Drug Deliv Rev; 2000 Mar; 41(1):75-89. PubMed ID: 10699306
[TBL] [Abstract][Full Text] [Related]
8. Fluorine nuclear magnetic resonance spectroscopy of human biofluids in the field of metabolic studies of anticancer and antifungal fluoropyrimidine drugs.
Malet-Martino M; Gilard V; Desmoulin F; Martino R
Clin Chim Acta; 2006 Apr; 366(1-2):61-73. PubMed ID: 16337167
[TBL] [Abstract][Full Text] [Related]
9. Monitoring fluoropyrimidine metabolism in solid tumors with in vivo (19)F magnetic resonance spectroscopy.
van Laarhoven HW; Punt CJ; Kamm YJ; Heerschap A
Crit Rev Oncol Hematol; 2005 Dec; 56(3):321-43. PubMed ID: 15982898
[TBL] [Abstract][Full Text] [Related]
10. [Application of multinuclear in vivo magnetic resonance spectroscopy in oncology].
Semmler W; Gückel F; Bachert-Baumann P; Lorenz WJ; van Kaick G
Radiologe; 1989 Jul; 29(7):330-5. PubMed ID: 2667032
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of tegafur in rat liver observed by in vivo 19F magnetic resonance spectroscopy and chromatography.
Harada M; Nishitani H; Koga K; Miura I; Umeno Y
Jpn J Cancer Res; 1992 Apr; 83(4):387-91. PubMed ID: 1506273
[TBL] [Abstract][Full Text] [Related]
12. Pyrimidine nucleoside analogs in cancer treatment.
Galmarini CM; Jordheim L; Dumontet C
Expert Rev Anticancer Ther; 2003 Oct; 3(5):717-28. PubMed ID: 14599094
[TBL] [Abstract][Full Text] [Related]
13. 19F NMR spectrometry evidence for bile acid conjugates of alpha-fluoro-beta-alanine as the main biliary metabolites of antineoplastic fluoropyrimidines in humans.
Malet-Martino MC; Bernadou J; Martino R; Armand JP
Drug Metab Dispos; 1988; 16(1):78-84. PubMed ID: 2894959
[TBL] [Abstract][Full Text] [Related]
14. In-Vivo Detection and Tracking of T Cells in Various Organs in a Melanoma Tumor Model by 19F-Fluorine MRS/MRI.
Gonzales C; Yoshihara HA; Dilek N; Leignadier J; Irving M; Mieville P; Helm L; Michielin O; Schwitter J
PLoS One; 2016; 11(10):e0164557. PubMed ID: 27736925
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive MRS in new anticancer drug development.
Workman P; Maxwell RJ; Griffiths JR
NMR Biomed; 1992; 5(5):270-2. PubMed ID: 1449967
[TBL] [Abstract][Full Text] [Related]
16. Heteronuclear 19F-1H statistical total correlation spectroscopy as a tool in drug metabolism: study of flucloxacillin biotransformation.
Keun HC; Athersuch TJ; Beckonert O; Wang Y; Saric J; Shockcor JP; Lindon JC; Wilson ID; Holmes E; Nicholson JK
Anal Chem; 2008 Feb; 80(4):1073-9. PubMed ID: 18211034
[TBL] [Abstract][Full Text] [Related]
17. Pre-treatment energy status of primary rat tumours as the best predictor of response to 5-fluorouracil chemotherapy: a magnetic resonance spectroscopy study in vivo.
Lemaire LP; McSheehy PM; Griffiths JR
Cancer Chemother Pharmacol; 1998; 42(3):201-9. PubMed ID: 9685055
[TBL] [Abstract][Full Text] [Related]
18. In vivo 19F nuclear magnetic resonance spectroscopy: a potential monitor of 5-fluorouracil pharmacokinetics and metabolism.
Evelhoch JL
Invest New Drugs; 1989 Apr; 7(1):5-12. PubMed ID: 2661482
[TBL] [Abstract][Full Text] [Related]
19. Structure-intestinal transport and structure-metabolism correlations of some potential cancerostatic pyrimidine nucleosides in isolated rat jejunum.
Novotný L; Farghali H; Ryba M; Janků I; Beránek J
Cancer Chemother Pharmacol; 1984; 13(3):195-9. PubMed ID: 6488439
[TBL] [Abstract][Full Text] [Related]
20. Nuclear magnetic resonance spectroscopy: a review of neuropsychiatric applications.
Passe TJ; Charles HC; Rajagopalan P; Krishnan KR
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jul; 19(4):541-63. PubMed ID: 8588055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
